The approval by U.S. antitrust regulators of Pfizer Inc.'s (NYSE:PFE) acquisition of Wyeth is an outlier of how merger...
Join Business Exchange
to access the most
relevant content for you,
filtered by like-minded
business professionals.
Learn more
PHARMACEUTICAL INDUSTRY
The pharmaceutical industry operates under unique circumstances: Estimates of the cost to bring a single new drug to market range from $800 million to $1.2 billion, and on average, a patent’s life remaining upon FDA launch approval is only eight years. Thus, achieving the highest level of performance is critical to pharmaceutical companies. This topic is dedicated to marketing, market research, business operations, and management issues specific to the pharmaceutical industry.
Pharmaceutical Industry is part of Business Exchange, suggested by
Ken Rhines.
This topic contains
2,362 news
and
2,435 blog
items.
Read updated news, blogs, and resources about Pharmaceutical Industry. Find user-submitted articles and reactions on Pharmaceutical Industry from
like-minded professionals.
Most Active
The most active stories in this topic based on user activity.
Nov. 4 (Bloomberg) -- Merck KGaA of Germany is gambling an unproven therapy that spurs the immune system to attack...
The H1N1 virus has now become the dominant influenza virus around the globe, with high levels and an increase of...
Two weeks after Johnson & Johnson (NYSE:JNJ) reported mixed earnings, which tugged stocks downward, the world's...
World leaders meet at the illustrious NGP Summit in Florida to face up to economic woes.
When Onyx Pharmaceuticals Inc. (NASDAQ:ONXX) bought Proteolix Inc. on Oct. 12, (The Deal Pipeline subscription...
SAN DIEGO, Oct. 30 /PRNewswire-FirstCall/ -- In a speech today to the City Club of San Diego, John C. Lechleiter, Ph.D.
My, how far CME has come in the age of technology! It seems like just yesterday that CME was in the infancy stage of...
Sept. 25 (Bloomberg) -- GlaxoSmithKline Plc’s search outside its own laboratories for new drugs is getting more...
An explicit indicator of the government intervention in the Corporate strategies of Indian companies is a headliner in...
Once a powerful profit-machine, big pharma is stumbling ,the threat of further government intervention, drying product...
SAN FRANCISCO, Calif., Oct. 20 (SEND2PRESS NEWSWIRE) -- Epeius Biotechnologies Corporation, an emerging leader in the...
78 percent of US interested in mobile healthcare solutions
On Wednesday, Pfizer Inc. (NYSE:PFE) received approval from the FTC for its $68 billion acquisition of Wyeth.
The race to offer H1N1 flu vaccination is picking up pace. While global H1N1 vaccine manufacturers like Sanofi Pasteur,...
Since winning The Deal's Most Admired Corporate Dealmaker award in the healthcare category in 2008, Abbott Laboratories...
I am in the process of developing LogiPharma 2010, a conference for supply chain and logistics decision makers in the...
Amid rising flu concerns, three big drug companies have formed deals that give them rights to new vaccines.
AcelRx Pharmaceuticals has a handful of mid- and late-state clinical products in development, which would make this a...
Epeius Biotechnologies Reports Dose-Dependent Efficacy and Survival Benefits. SAN MARINO, Calif., Oct.
Tumor-targeted REXIN-G Quells Metastatic Osteosarcoma, Prostate Cancer, and Pancreas Cancer as Stand-alone Therapy.
Johnson & Johnson (NYSE:JNJ), the world's biggest healthcare company that's been squeezed by generic competition,...
Oncology deals keep coming. A week and a half after Sanofi-Aventis SA (NYSE:SNY) acquired the rights to sell an...
The drug giant suffers a setback in its effort to boost its oncology pipeline.
Our oncology M&A list keeps growing. Sanofi-Aventis SA (NYSE:SNY), which is already on it, is acquiring the rights...
Top Sources: Pharmaceutical Industry
- BusinessWeek
- New York Times
- srcomblog.wordpress.com
- bloomberg.com
- Health Beat
- Reuters
- The Atlantic Business Channel
- 247wallst.com
- online.wsj.com
- blogs.forbes.com
Tweets on this Topic










